Jill Blair, PT, DPT in Brasher Falls, NY - Physical Therapist

Jill Blair, PT, DPT is a Physical Therapist based in Brasher Falls, New York. Jill Blair is licensed to practice in New York (license number 033242-1) and her current practice location is 897 State Highway 11c Bay 4, Brasher Falls, New York. She can be reached at her office (for appointments etc.) via phone at (315) 389-5004.

NPI number for Jill Blair is 1194029603 and her current mailing address is 19 Maple St, Norfolk, New York. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1194029603.

Contact Information

	Jill Blair, PT, DPT
	897 State Highway 11c Bay 4, Brasher Falls, NY 13613-4118
	(315) 389-5004
	(315) 389-5504

Healthcare Provider's Profile

Full Name	Jill Blair
Gender	Female
Speciality	Physical Therapist
Location	897 State Highway 11c Bay 4, Brasher Falls, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1194029603
Provider Enumeration Date: 12/28/2010
Last Update Date: 01/23/2012

Medical Identifiers

Medical identifiers for Jill Blair such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1194029603	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	033242-1 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jill Blair is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jill Blair, PT, DPT 19 Maple St, Norfolk, NY 13667-3112 Ph: () -	Jill Blair, PT, DPT 897 State Highway 11c Bay 4, Brasher Falls, NY 13613-4118 Ph: (315) 389-5004

News Archive

New treatment may be on the horizon for Parkinson's disease

More of us are susceptible to Parkinson's as we age, as evidenced by actor Alan Alda's recent diagnosis. A new treatment may be on the horizon.

Novogen's Anisina granted FDA Orphan Drug Designation for neuroblastoma

US-Australian drug discovery company, Novogen Limited, today announced that it has received notification from the U.S. Food and Drug Administration that its chemotherapy candidate drug, Anisina, has been granted Orphan Drug Designation for neuroblastoma.

Booming Australian cosmetic surgery industry to be reeled in

As more and more revelations come to light about unsuccessful cosmetic surgical procedures carried out in Australia, state Governments are considering ways to exert more control over the burgeoning industry.

InSite and Senju collaborate to develop and market azithromycin ophthalmic solution using DuraSite

InSite Vision Incorporated and Senju Pharmaceutical Co., Ltd. today announced that they have entered into a collaboration and license agreement to develop and market InSite's azithromycin ophthalmic solution using DuraSite® including AzaSite® 1% and AzaSite XtraTM 2% ocular antibiotics in Japan. Senju has agreed to pay InSite an upfront license fee, additional development milestones fees, and a percentage royalty on net sales.

Jill Blair, PT, DPT - Physical Therapist in Brasher Falls, NY